Meeker-O'Connell Ann, Borda Maria Magdalena, Little Janis A, Sam Leslie M
1 BioResearch Quality and Compliance, Johnson & Johnson, New Brunswick, NJ, USA.
2 Pharma Development Quality, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Ther Innov Regul Sci. 2015 Sep;49(5):615-622. doi: 10.1177/2168479015596018.
A quality management system (QMS) is an integrated framework through which organizations can systematically plan and achieve their quality objectives. While the International Conference on Harmonisation (ICH) Q10 provides clear guidance for QMS in the pharmaceutical manufacturing sector, there is no harmonized regulatory guidance describing a framework that provides an enterprise-wide view of achievement of clinical quality objectives, that is capable of being customized to fit an organization's unique circumstances, and that accommodates the variability inherent in clinical development. In the absence of such guidance, clinical QMS varies dramatically across industry, sometimes resulting in over-engineered, cumbersome systems that are not adaptable or fit-for-purpose. This paper will describe the ongoing activities of a TransCelerate initiative developing a conceptual framework for a Clinical QMS designed to provide a consistent, streamlined, and proactive quality approach across all stages of clinical research.
质量管理体系(QMS)是一个综合框架,组织可通过该框架系统地规划并实现其质量目标。虽然国际协调会议(ICH)的Q10为制药生产领域的质量管理体系提供了明确指导,但目前尚无统一的监管指南来描述这样一个框架,该框架能够从企业层面全面审视临床质量目标的达成情况,能够根据组织的独特情况进行定制,并且能够适应临床开发中固有的变异性。由于缺乏此类指导,临床质量管理体系在整个行业中差异巨大,有时会导致设计过度、繁琐且无法适应或不符合目的的系统。本文将介绍加速医药研发合作组织(TransCelerate)的一项正在进行的计划,该计划旨在为临床质量管理体系开发一个概念框架,以便在临床研究的各个阶段提供一致、简化且积极主动的质量方法。